4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Evaluation of the Informational Content and Readability of US Lung Cancer Screening Program Websites

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This cross-sectional study evaluates the informational content and readability of US lung cancer screening program websites.

          Key Points

          Question

          Is the informational content of lung cancer screening program websites in the United States accurate, complete, and presented at an appropriate reading level for most patients?

          Findings

          In this cross-sectional study of 257 lung cancer screening program websites, there was large variability regarding information on enrollment criteria, benefits and risks, logistics, and costs of lung cancer screening. The reading level of the websites was consistently above that of the average adult in the United States and the level recommended by the American Medical Association and the National Institutes of Health.

          Meaning

          Efforts to improve the content and readability of program websites may be warranted to improve patient understanding of lung cancer screening.

          Abstract

          Importance

          The internet is an important source of medical information for many patients and may have a key role in the education of patients about lung cancer screening (LCS). Although most LCS programs in the United States have informational websites, the accuracy, completeness, and readability of these websites have not previously been studied.

          Objective

          To evaluate the informational content and readability of US LCS program websites.

          Design, Setting, and Participants

          This cross-sectional study assessed US LCS program websites identified on September 15, 2018. A standardized checklist was used to assess key informational content of each website, and text was analyzed for reading level, word count, and reading time. Links to US websites of national advocacy organizations with LCS program content were tabulated. All functional LCS program websites in Google internet search engine results using the search terms lung cancer screening, low-dose CT screening, and lung screening were included in the analysis.

          Main Outcomes and Measures

          Radiologists used a standardized checklist to evaluate content, and readability was assessed with validated scales. Website word count, reading time, and number of links to outside LCS informational websites were assessed.

          Results

          A total of 257 LCS websites were included in the analysis. The word count ranged from 73 to 4410 (median, 571; interquartile range, 328-909). The reading time ranged from 0.3 to 19.6 minutes (median, 2.5; interquartile range, 1.5-4.0). The median reading level of all websites was grade 10 (interquartile range, 9-11). Only 26% (n = 66) of websites had at least 1 web link to a national website with additional information on LCS. There was wide variability regarding reported eligibility age criteria, with ages 55 to 77 years most frequently cited (42% [n = 108]). Only 56% (n = 143) of websites mentioned smoking cessation. The subject of patient cost was mentioned on 75% (n = 192) of websites. Although major LCS benefits, such as detection of lung cancer, were discussed by most (93% [n = 239]) websites, less than half of the websites (45% [n = 115]) made any mention of possible risks associated with screening.

          Conclusions and Relevance

          There appears to be marked variability in the informational content of US LCS program websites, and the reading level of most websites is above that recommended by the American Medical Association and the National Institutes of Health. Efforts to improve website content and readability may be warranted.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          American Cancer Society lung cancer screening guidelines.

          Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation. Copyright © 2013 American Cancer Society, Inc.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A computer readability formula designed for machine scoring.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Screening for Lung Cancer

              Low-dose chest CT screening for lung cancer has become a standard of care in the United States in the past few years, in large part due to the results of the National Lung Screening Trial. The benefit and harms of low-dose chest CT screening differ in both frequency and magnitude. The translation of a favorable balance of benefit and harms into practice can be difficult. Here, we update the evidence base for the benefit, harms, and implementation of low radiation dose chest CT screening. We use the updated evidence base to provide recommendations where the evidence allows, and statements based on experience and expert consensus where it does not.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                31 January 2020
                January 2020
                31 January 2020
                : 3
                : 1
                : e1920431
                Affiliations
                [1 ]Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts
                [2 ]Thoracic Imaging and Intervention Division, Department of Radiology, Massachusetts General Hospital, Boston
                [3 ]Department of Radiology, Mayo Clinic, Jacksonville, Florida
                Author notes
                Article Information
                Accepted for Publication: December 3, 2019.
                Published: January 31, 2020. doi:10.1001/jamanetworkopen.2019.20431
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Gagne SM et al. JAMA Network Open.
                Corresponding Author: Brent P. Little, MD, Thoracic Imaging and Intervention Division, Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114 ( blittle@ 123456partners.org ).
                Author Contributions: Drs Gagne and Little had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Fintelmann, Flores, Little.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Gagne, Flores, Little.
                Critical revision of the manuscript for important intellectual content: All authors.
                Statistical analysis: Flores, Petranovic, Little.
                Administrative, technical, or material support: Gagne, McDermott, Mendoza.
                Supervision: Flores, Little.
                Conflict of Interest Disclosures: Dr Fintelmann reported receiving consulting fees from McKesson, nonfinancial support from BTG plc, and research grants from the Society of Thoracic Radiology, the Society of Interventional Oncology, and the American Roentgen Ray Society. Dr Little reported being an academic textbook associate editor and author of textbook chapters for Reed Elsevier, Inc and receiving royalties for his work. No other disclosures were reported.
                Article
                zoi190765
                10.1001/jamanetworkopen.2019.20431
                7042868
                32003825
                28f1c2dc-00bc-4e87-9280-d8f507932670
                Copyright 2020 Gagne SM et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 19 September 2019
                : 3 December 2019
                Categories
                Research
                Original Investigation
                Online Only
                Imaging

                Comments

                Comment on this article